A 6-year-old boy from rural Maharashtra presents with acute onset watery diarrhea, abdominal cramps, and fever for 2 days. Stool microscopy shows RBCs and WBCs. Culture on HE agar shows non-motile, lactose-fermenting colonies. Biochemical tests confirm Shigella flexneri. The child is moderately dehydrated but hemodynamically stable. What is the most appropriate immediate next step in management?

Explanation

## Management of Confirmed Shigella flexneri Dysentery ### Clinical Context This child presents with **confirmed Shigella flexneri dysentery** — bloody/mucoid diarrhea with fever, RBCs and WBCs on stool microscopy, and culture-confirmed organism. He is moderately dehydrated but hemodynamically stable. ### Key Management Principle **High-Yield:** Unlike simple watery diarrhea (e.g., ETEC, rotavirus), **Shigella dysentery is an indication for antibiotic therapy in ALL confirmed or strongly suspected cases**, regardless of severity. This is a critical distinction from other diarrheal illnesses. **Key Point (WHO / IAP / Harrison's):** Antibiotics are recommended for ALL cases of shigellosis because they: 1. Shorten the duration of illness (from ~7 days to ~3 days) 2. Reduce fecal shedding and transmission 3. Prevent complications (HUS, toxic megacolon, sepsis, malnutrition) 4. Are especially important in children, where complications are more common This is explicitly stated in **Harrison's Principles of Internal Medicine (21st ed.)** and **WHO guidelines on shigellosis**: *"All patients with shigellosis should receive antibiotic therapy."* ### Why Option B (Ciprofloxacin) is Correct **Clinical Pearl:** Fluoroquinolones (ciprofloxacin) remain the **empirical first-line agent** for shigellosis in most guidelines, including WHO and IAP, pending local susceptibility data. While fluoroquinolone resistance is a concern in India, empirical therapy is still initiated immediately — susceptibility testing guides de-escalation or switch, not the decision to treat. - **Ciprofloxacin dose:** 15 mg/kg/dose BD × 3 days (pediatric) - Simultaneously, **ORS is administered** for rehydration — this is supportive care that accompanies, not replaces, antibiotic therapy ### Why Option A is Incorrect Reserving antibiotics only for "severe disease or complications" is the approach for **non-dysenteric diarrhea** (e.g., watery diarrhea from viral or ETEC causes). For **confirmed Shigella dysentery**, withholding antibiotics is not evidence-based and increases risk of complications and transmission. ### Antibiotic Selection for Shigellosis | Setting | First-Line | Alternative | |---------|-----------|-------------| | Empirical (all ages) | Ciprofloxacin | Azithromycin | | Fluoroquinolone-resistant | Azithromycin | Ceftriaxone (IV, severe) | | Severe/IV route needed | Ceftriaxone IV | Azithromycin IV | ### Why Other Options Are Incorrect - **Option C (IV ceftriaxone + admission):** Reserved for severe disease, sepsis, or inability to tolerate oral therapy. This child is stable and can receive oral therapy. - **Option D (Blood culture + imaging before treatment):** Unnecessary delay in a confirmed, uncomplicated case. Blood cultures are indicated only if bacteremia/sepsis is suspected. **Key Point:** ORS is given concurrently for rehydration, but the **most appropriate immediate next step** — the action that distinguishes Shigella management from other diarrheas — is starting empirical antibiotic therapy with ciprofloxacin. *Reference: Harrison's Principles of Internal Medicine, 21st ed.; WHO Guidelines for the Control of Shigellosis; IAP Standard Treatment Guidelines.*